Keep this in mind, while the stock wallows in the low two-digits. Dr. Mullan has a deferred base salary, accepting shares in lieu of deferred salary.
So, if you accept shares in lieu of salary, isn't it better that the stock trades extremely low. Simple math:
$600,000 (his base salary for 2016) divided by .11 cents (current stock price). That works out to approximately 5,500,000 shares (yes, 5.5 million shares!). Compare that to a stock price of $2 / share, which is a relatively meager 300,000 shares.
Now, would you be in a hurry to move the stock higher? And I know that this is on a weighted average, but the general idea is a lower stock price actually helps the good doctor.
